The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / RheumPAC Hosts Rep. Ami Bera (D-Calif.) for Virtual Discussion of ACR Legislative Priorities

RheumPAC Hosts Rep. Ami Bera (D-Calif.) for Virtual Discussion of ACR Legislative Priorities

May 20, 2020 • By From the College

  • Tweet
  • Email
Print-Friendly Version / Save PDF

During the COVID-19 pandemic, RheumPAC is continuing to find innovative ways to connect with and educate lawmakers about the issues facing rheumatology and to reward its most generous supporters. On Tuesday, May 12, the ACR held its first RheumPAC Happy Hour, which consisted of a virtual legislative update and Q&A with Rep. Ami Bera, MD (D-Calif.), who is one of 17 physicians serving in Congress.

You Might Also Like
  • Board Members Lobby Congress on Arthritis Act and Other Legislative Priorities
  • The ACR’s 2018 Legislative & Regulatory Priorities
  • The ACR’s 2018 Legislative & Regulatory Priorities
Also By This Author
  • How to Navigate & Manage Insurance Overpayments

ACR President Ellen Gravallese, MD, opened the call with an introduction to Rep. Bera about the importance of preserving patient access to rheumatology care through continued financial support of providers. The timing could not have been better because Democrats in the House of Representatives had released their $3 trillion coronavirus response plan earlier that day. Rep. Bera was able to offer insight into important healthcare provisions included in the plan and the next steps needed to get legislation passed in both the House and Senate.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The rest of the call consisted of a Q&A moderated by RheumPAC Chair Zachary Wallace, MD, MSc. The attendees, comprising donors who contributed at the Silver level and above ($250 or more for ACR members, $150 or more for FIT/ARP members) in 2019 and 2020, appreciated hearing firsthand from Rep. Bera the latest information about activities in Washington, D.C.

During the discussion, Rep. Bera commented that he:

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE
  • Was impressed by how rapidly the clinical trials for a COVID vaccine are moving;
  • Anticipates an expansion in funding for biomedical research;
  • Anticipates a long-term impact on our current employer-based healthcare coverage system; and
  • Sees opportunity in the crisis to highlight ACR’s workforce initiatives, because the need for a robust healthcare workforce and recruitment to this industry are clearer than ever.

Additionally, Rep. Bera provided an informed and insightful outlook on questions regarding telehealth parity, drug pricing, workforce shortages and the status of other ACR legislative priorities.

RheumPAC will continue to communicate ACR legislative concerns to members of Congress and hopes to provide additional opportunities for virtual interactions between ACR/ARP members and legislators. Stay tuned for future events.

Filed Under: Legislation & Advocacy Tagged With: Rep. Ami Bera, RheumPAC

You Might Also Like:
  • Board Members Lobby Congress on Arthritis Act and Other Legislative Priorities
  • The ACR’s 2018 Legislative & Regulatory Priorities
  • The ACR’s 2018 Legislative & Regulatory Priorities
  • Legislative Priorities in 2007

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)